Abstract
Background Early identification of pediatric patients at high risk for dengue shock syndrome (DSS) is crucial to enable timely and appropriate clinical interventions. However, the application of machine learning (ML) models for predicting DSS risk remains underexplored. Objective This study aimed to develop and validate a ML-based nomogram for predicting DSS risk in pediatric patients with dengue fever, supporting clinical decision-making. Methods A prospective study was conducted on 230 children with dengue fever admitted to Can Tho Children's Hospital, Vietnam, from January 2020 to December 2022. Clinical and laboratory data were collected and analyzed using R software (version 4.4.1). Six ML algorithms were used to develop risk prediction models for hospitalized pediatric patients with dengue, and their predictive performances were compared. The best-performing model was used to construct a nomogram for DSS prediction. Model performance was evaluated using the area under the receiver operating characteristic curve (AUROC), and the calibration of the nomogram was assessed using a calibration curve. Results Among the 230 dengue patients enrolled, 124 (53.9%) were male, with a median age of 11 years (IQR: 8-13 years). The cohort was randomly divided into a training set (n = 173) and a test set (n = 57). Five key predictors selected for the nomogram were albumin, activated partial thromboplastin time (APTT), fibrinogen, aspartate aminotransferase (AST), and platelet count. In the test set, the AUROC for the six models ranged from 0.888 to 0.945. The random forest model demonstrated the best performance, with an AUROC of 0.945 (95% CI: 0.886-1.000), an accuracy of 0.951 (95% CI: 0.865-0.989), sensitivity of 0.894, specificity of 0.976, and a Kappa score of 0.884. Conclusions ML-based models can be established and potentially help identify hospitalized pediatric patients with dengue who are at high risk of progressing to DSS. The proposed nomogram may be a valuable tool for predicting DSS in clinical practice.